User: prashantiyengar Topic: IP
Category: patents :: india
Last updated: Apr 23 2014 19:01 IST RSS 2.0
 
1 to 20 of 5,027    
Pfizer complains about India’s intellectual property regime again (Cached) 23.4.2014 ET: Pharma
In a letter, US pharma giant Pfizer has urged the Indian government to “shift from using destructive IP policy as an access strategy”.
Also found in: [+]
Novartis buys Glaxo’s cancer arm for $16 billion (Cached) 23.4.2014 TOI: Intl Business
Novartis will focus more on cancer, GlaxoSmithKline on vaccines and Eli Lilly & Co on animal health as the drugmakers announced a series of deals for a total of as much as $28.5 billion.
Also found in: [+]
Pfizer, AstraZeneca shares climb up amidst deal talks (Cached) 23.4.2014 ET: Pharma
The two drugmakers declined to confirm the development, even as the news sent market punters to bet on the likely impact on its Indian subsidiaries.
Also found in: [+]
US pharmaceutical giant Pfizer keen to acquire AstraZeneaca for $100 billion (Cached) 22.4.2014 New Kerala: Business India
Washington, Apr 21 : US based pharmaceutical company Pfizer has proposed to take over its British rival AstraZeneca for 60 billion pounds (101 billion dollars).
Also found in: [+]
Indian govt prepares to battle US pressure on trade laws (Cached) 22.4.2014 Rediff: Business
A certain segment of the US pharma industry have become vocal about Indian policies on domestic content requirements and IPR.
Also found in: [+]
Indian universities should be able to challenge the frontiers of knowledge: Avinash Chander (Cached) 19.4.2014 ET: Education
Indian universities should be able to challenge the frontiers of knowledge while supporting innovation, said DRDO chief Avinash Chander.
Also found in: [+]
OnMobile settles patent infringement dispute with US firm (Cached) 19.4.2014 TOI: India Business
Mobile VAS company OnMobile has settled a patent infringement case with US-based Synchronoss Technologies for $ 3 million or about Rs 18 crore.
Also found in: [+]
Urgent drill to counter US trade threat (Cached) 19.4.2014 Telegraph: Business
New Delhi, April 18: India is getting ready for the mother of all trade spats ' a confrontation with the US, which accounts for trade worth $70 billion annually, over pharma and telecom.
Also found in: [+]
Lok Sabha Elections 2014: Erode has potential to become a textile heaven says Narendra Modi 17.4.2014 DNA: Recent Columns
Bharatiya Janata Party's (BJP) prime ministerial candidate Narendra Modi on Thursday said that Erode has the potential to become a textile heaven, and that its turmeric was world famous, which could change the face of the state's employment scenario if right initiatives were taken. "India loves the turmeric of Erode as it makes our food tasty and colourful. He said that U.S had once sought patent for turmeric which had its medicinal and cosmetic usage since herbal products is growing on a large scale. Modi said that medicines and cosmetics from turmeric can change Erode's economy. BJP will give a special focus to develop herbal medicine and ayurveda and increase research and establish made in India brand," Modi said at a rally in Erode. Modi also talked about Erode's textile industry and asked Rahul Gandhi and Sonia Gandhi that why proper measures were not taken to give jobs to youth in this sector. "Erode district has the potential to be a textile heaven as all the components of the textile industry are ...
Also found in: [+]
Infosys Q4 result beats forecast (Cached) 15.4.2014 New Kerala: Business India
Bangalore, Apr 15 : IT bellwether Infosys on Tuesday announced a better-than-expected result for its March quarter with FY 14 revenue growth doubling to 11.5% in USD terms; increased to 24.2% in INR terms, and the net profit at Rs 2,992 crore with a QoQ growth at 4.1% and YoY growth at 25.0%.
Also found in: [+]
Indian patent and pharma laws should not be considered discriminatory: Public Citizen (Cached) 15.4.2014 ET: Policy
In a submission to US International Trade Commission, 'Public Citizen' said that India's rules meet the data protection requirements.
Also found in: [+]
Google says it never copied iPhone features for Android (Cached) 14.4.2014 New Kerala: Business India
Washington, Apr. 13 : A Google executive has reportedly said that Google engineers have never copied Apple's iPhone features for use in Android.
Also found in: [+]
Natco seeks to block Gilead's hepatitis C drug patent in India: Report (Cached) 10.4.2014 ET: Pharma
Natco Pharma Ltd has formally asked the Indian patent office to deny US drugmaker Gilead Sciences Inc's new hepatitis C drug Sovaldi a patent in India.
Also found in: [+]
Here's why Apple is seeking $2.2Bln claim from Samsung (Cached) 10.4.2014 New Kerala: World News
Washington, Apr 10 : Apple has accounted a claim of 2.2 billion dollars against Samsung Electronics, demanding money for the lost sales and royalties the company faced.
Also found in: [+]
Teva's patent plea rejected in US: Natco (Cached) 7.4.2014 TOI: India Business
Hyderabad-based Natco Pharma said on Friday in a BSE filing that the US Patent and Trademark Office (PTO) has issued a final office action rejecting Israel-based Teva Pharma's application on its blockbuster drug Copaxone.
Also found in: [+]
Apple document says 'consumers want what we don't have' (Cached) 6.4.2014 New Kerala: World News
Washington, Apr 6 : Apple's internal documents that were presented in a court have reportedly revealed that the company is concerned about the declining iPhone sales.
Also found in: [+]
Patent attorneys demand fair deal for Indian applicants (Cached) 5.4.2014 TOI: India Business
Highlighting a major anomaly in the Indian Patents Act, 1970 which provides for fast-track award of patent to foreign entities, attorneys specializing in patents have demanded similar facility for individuals and companies from India as well.
Also found in: [+]
Free trade agreements contain provisions that restrict access to medicines: UNITAID (Cached) 5.4.2014 TOI: Intl Business
UNITAID, a global health initiative has warned against bilateral and regional trade agreements, pushed mostly by Europe and the US, as such agreements go well beyond traditional trade concerns and include provisions that force extensive obligations related to intellectual property and investor protection which would restrict access to medicines.
Also found in: [+]
US Patents rejects Teva's plea on Copaxone; Natco shares up (Cached) 5.4.2014 TOI: India Business
The US Patent and Trademark Office has rejected the application of Israel’s Teva Pharmaceutical seeking reissue of patent for its blockbuster multiple sclerosis drug Copaxone.
Also found in: [+]
Drugs giant Biocon rejects Novartis patent accusations (Cached) 4.4.2014 ET: Pharma
Biocon on Friday rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for its blockbuster diabetes drug Galvus.
Also found in: [+]
1 to 20 of 5,027